Clinical Trial Update: Long Term Safety Trial to Compare Insulin Treatment With Preprandial Inhaled Human Insulin to s.c. Insulin Aspart Both Combined With NPH in Subjects With Type 1 Diabetes [Phase 3]

View source ↗

Summary

A Phase 3 long-term safety trial compares preprandial inhaled human insulin with subcutaneous insulin aspart, both given with NPH, in subjects with Type 1 diabe…

Upgrade for the full analysis, importance score, and drug timeline.

Diseases / indications

• Type 1 Diabetes Mellitus

Drugs mentioned

• Inhaled human insulin (insulin inhalation)
• Insulin aspart (insulin aspart)
• insulin isophane (NPH) (insulin isophane)

Snippet

Sponsor: Novo Nordisk A/S | Conditions: Diabetes, Diabetes Mellitus, Type 1 | Phase 3 | Status: COMPLETED